Yuanjun Yang: Clinical Trials

3 unknown, 2 active not recruiting, 1 recruiting. 2 Not applicable.

By phase and status

Phase	Trials	Status
Not applicable	2	Recruiting 1, Unknown 1

Follow Yuanjun Yang: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Changes in Renal Perfusion During Hemodialysis in Patients with End-stage Renal Disease End-stage Renal Disease		Unknown	Yuanjun Yang	20	2024-09-05	2024-09-19
Effect of Glycosuria on Urinary Protein in Patients With Chronic Kidney Disease Treated With SGLT2 Inhibitors Chronic Kidney Disease		Active not recruiting	Yuanjun Yang	300	2024-07-01	2025-09-03
Hemodialysis-Induced Renal Perfusion Decline: Unraveling the Pathophysiological Mechanisms Linking Intradialytic Circulatory Stress to Residual Renal Function Loss CEUS examinations - End-Stage Renal Disease Requiring Haemodialysis		Active not recruiting	Yuanjun Yang	30	2024-05-01	2025-06-04
The Renal Protective Effects of Remote Ischemic Preconditioning in Patients With Chronic Kidney Disease Remote ischemic conditioning - Chronic Kidney Diseases	Not applicable	Recruiting	Yuanjun Yang	114	2024-03-01	2024-08-19
The Protective Effect of Remote Ischemic Conditioning on Residual Renal Function in Hemodialysis Patients (RIC-HD) Remote ischemic conditioning, Sham Remote Ischemic Conditioning - End-stage Renal Disease	Not applicable	Unknown	Yuanjun Yang	60	2024-02-20	2024-02-26
NIRS for the Diagnosis of Residual Renal Function Injury in Hemodialysis Patients End-stage Renal Disease (ESRD)		Unknown	Yuanjun Yang	30	2024-02-15	2024-02-06

Conditions studied

Kidney Failure, Chronic (3)  ·  Renal Insufficiency, Chronic (2)

Countries

China (5)

Top investigators

Guangyan Cai (3)  ·  Guangyan Cai, PhD (1)

Results publications

PMID 41190031